REGENXBIO, Inc.
(NASDAQ : RGNX)

( )
RGNX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
1.02%73.340.9%$603.58m
CELGCelgene Corporation
2.24%130.291.1%$443.49m
AMGNAmgen Inc.
1.14%170.071.1%$408.88m
BIIBBiogen Inc.
1.26%286.721.2%$356.69m
REGNRegeneron Pharmaceuticals, Inc.
1.90%478.652.7%$320.91m
VRTXVertex Pharmaceuticals Incorporated
4.34%155.481.9%$240.46m
ALXNAlexion Pharmaceuticals, Inc.
3.58%138.201.9%$220.20m
ILMNIllumina, Inc.
2.14%194.763.5%$214.91m
INCYIncyte Corporation
2.46%123.862.6%$133.37m
KITEKite Pharma, Inc.
1.52%135.9516.1%$128.55m
CLVSClovis Oncology, Inc.
1.24%72.0818.0%$127.98m
TSROTESARO, Inc.
1.48%120.6214.7%$126.99m
AAgilent Technologies, Inc.
1.93%62.931.5%$121.42m
BMRNBioMarin Pharmaceutical Inc.
1.07%81.464.4%$105.18m
SRPTSarepta Therapeutics, Inc.
3.41%36.9519.8%$99.21m

Company Profile

REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.